These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Iloprost for pulmonary vasodilator testing in idiopathic pulmonary arterial hypertension. Jing ZC, Jiang X, Han ZY, Xu XQ, Wang Y, Wu Y, Lv H, Ma CR, Yang YJ, Pu JL. Eur Respir J; 2009 Jun; 33(6):1354-60. PubMed ID: 19213781 [Abstract] [Full Text] [Related]
3. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Sitbon O, Humbert M, Jaïs X, Ioos V, Hamid AM, Provencher S, Garcia G, Parent F, Hervé P, Simonneau G. Circulation; 2005 Jun 14; 111(23):3105-11. PubMed ID: 15939821 [Abstract] [Full Text] [Related]
4. Pulmonary vasodilator testing and use of calcium channel blockers in pulmonary arterial hypertension. Tonelli AR, Alnuaimat H, Mubarak K. Respir Med; 2010 Apr 14; 104(4):481-96. PubMed ID: 20004088 [Abstract] [Full Text] [Related]
15. Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension. Montani D, Savale L, Natali D, Jaïs X, Herve P, Garcia G, Humbert M, Simonneau G, Sitbon O. Eur Heart J; 2010 Aug 14; 31(15):1898-907. PubMed ID: 20543192 [Abstract] [Full Text] [Related]
16. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. McLaughlin VV, Genthner DE, Panella MM, Rich S. N Engl J Med; 1998 Jan 29; 338(5):273-7. PubMed ID: 9445406 [Abstract] [Full Text] [Related]
20. Acute hemodynamic responses to adenosine and iloprost in patients with congenital heart defects and severe pulmonary arterial hypertension. Zhang DZ, Zhu XY, Meng J, Xue HM, Sheng XT, Han XM, Cui CS, Wang QG, Zhang P. Int J Cardiol; 2011 Mar 17; 147(3):433-7. PubMed ID: 20537740 [Abstract] [Full Text] [Related] Page: [Next] [New Search]